The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.
暂无分享,去创建一个
[1] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[2] R. DePinho,et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.
[3] David K. Finlay,et al. Phosphoinositide 3‐kinase and the mammalian target of rapamycin pathways control T cell migration , 2010, Annals of the New York Academy of Sciences.
[4] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[5] R. Mills,et al. T cell dependence on mTOR signaling , 2009, Cell cycle.
[6] B. Bierer,et al. Ex Vivo Rapamycin Generates Donor Th2 Cells That Potently Inhibit Graft-versus-Host Disease and Graft-versus-Tumor Effects via an IL-4-Dependent Mechanism1 , 2005, The Journal of Immunology.
[7] Daniel L. Popkin,et al. A Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence , 2010, Nature Immunology.
[8] R. Proia,et al. S1P1 receptor overrides regulatory T cell-mediated immune suppression through Akt-mTOR , 2009, Nature Immunology.
[9] M. Jenkins,et al. The role of cell division in the induction of clonal anergy. , 1992, Immunology today.
[10] G. Thomas,et al. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. , 1999, Current opinion in genetics & development.
[11] G. de la Rosa,et al. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. , 2007, International immunopharmacology.
[12] V. Lazar,et al. FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.
[13] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[14] Craig B. Thompson,et al. Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.
[15] Ying Wang,et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. , 2010, The Journal of clinical investigation.
[16] Erika L. Pearce. Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.
[17] A. Khoruts,et al. De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR , 2008, Journal of leukocyte biology.
[18] K. Frauwirth,et al. Regulation of T lymphocyte metabolism , 2004, Brain, Behavior, and Immunity.
[19] Kathy O. Lui,et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling , 2009, Proceedings of the National Academy of Sciences.
[20] V. Basso,et al. Clonal Anergy Is Maintained Independently of T Cell Proliferation1 , 2002, The Journal of Immunology.
[21] M. Battaglia,et al. Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.
[22] M. Merkenschlager,et al. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors , 2010, The Journal of experimental medicine.
[23] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[24] M. Horton,et al. The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction1 , 2004, The Journal of Immunology.
[25] T. Whiteside,et al. Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin , 2009, PloS one.
[26] P. Linsley,et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Russell G. Jones,et al. Revving the engine: signal transduction fuels T cell activation. , 2007, Immunity.
[28] C. Proud,et al. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. , 2003, The Biochemical journal.
[29] Chin-Lee Wu,et al. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. , 2009, Cancer research.
[30] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[31] M. Battaglia,et al. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.
[32] Qingsheng Li,et al. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.
[33] A. Khoruts,et al. Antagonistic Roles for CTLA-4 and the Mammalian Target of Rapamycin in the Regulation of Clonal Anergy: Enhanced Cell Cycle Progression Promotes Recall Antigen Responsiveness1 , 2001, The Journal of Immunology.
[34] D. Harlan,et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy , 2002, The Lancet.
[35] C. Thompson,et al. The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.
[36] M. Boothby,et al. Sequence Motifs in IL-4Rα Mediating Cell-Cycle Progression of Primary Lymphocytes1 , 2005, The Journal of Immunology.
[37] C. June,et al. Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin1 , 2008, The Journal of Immunology.
[38] C. Janeway. Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.
[39] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[40] C. Spencer,et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.
[41] G. Szot,et al. Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes , 2009, Diabetes.
[42] Y. Ip,et al. Regulators of the Toll and Imd pathways in the Drosophila innate immune response. , 2005, Trends in immunology.
[43] L. Platanias,et al. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. , 2004, Experimental cell research.
[44] Anne F. Buckley,et al. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway , 2001, Nature Immunology.
[45] Greg M. Delgoffe,et al. mTOR: taking cues from the immune microenvironment , 2009, Immunology.
[46] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[47] D. Sabatini,et al. mTOR signaling at a glance , 2009, Journal of Cell Science.
[48] R. Ahmed,et al. The role of mTOR in memory CD8+ T‐cell differentiation , 2010, Immunological reviews.
[49] B. Levine,et al. T Regulatory Expansion and Function CD 28 Costimulation Is Essential for Human June and , 2008 .
[50] A. Sharpe. Mechanisms of costimulation , 2009, Immunological reviews.
[51] E. Wherry,et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin , 2005, Nature Immunology.
[52] C. Benoist,et al. The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.
[53] Loise M. Francisco,et al. OR.100. PD-L1 Regulates the Development, Maintenance and Function of Induced-regulatory T Cells , 2009 .
[54] D. Munn,et al. Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.
[55] Nikhil S. Joshi,et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.
[56] B. Levine,et al. CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function1 , 2008, The Journal of Immunology.
[57] B. Edgar,et al. Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.
[58] P. Matzinger,et al. Is cancer dangerous to the immune system? , 1996, Seminars in immunology.
[59] M. V. Heiden,et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. , 2000, Immunity.
[60] David M. Sabatini,et al. An Emerging Role of mTOR in Lipid Biosynthesis , 2009, Current Biology.
[61] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[62] Corey M. Carlson,et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration , 2006, Nature.
[63] Volkmar Braun,et al. Colicins: structures, modes of action, transfer through membranes, and evolution , 1994, Archives of Microbiology.
[64] L. Cantley,et al. Rheb fills a GAP between TSC and TOR. , 2003, Trends in biochemical sciences.
[65] K. Shokat,et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.
[66] M. Boothby,et al. Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes. , 2005, Journal of immunology.
[67] R. Proia,et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.
[68] K. Inoki,et al. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.
[69] T. Gajewski,et al. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells , 2008, European journal of immunology.
[70] G. Filomeni,et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[71] Jonathan D. Powell,et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.
[72] Y. Toda,et al. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[73] P. Worley,et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.
[74] M. Rossi,et al. IL-4 regulates susceptibility to intestinal inflammation in murine food allergy Running head : IL-4 in allergic intestinal inflammation , 2008 .
[75] E. Wherry,et al. Cutting Edge: IL-12 Inversely Regulates T-bet and Eomesodermin Expression during Pathogen-Induced CD8+ T Cell Differentiation1 , 2006, The Journal of Immunology.
[76] Greg M. Delgoffe,et al. Anergic T Cells Are Metabolically Anergic1 , 2009, The Journal of Immunology.
[77] R. Ahmed,et al. mTOR regulates memory CD8 T cell differentiation , 2009, Nature.
[78] I. Kang,et al. AICAR suppresses IL-2 expression through inhibition of GSK-3 phosphorylation and NF-AT activation in Jurkat T cells. , 2005, Biochemical and biophysical research communications.
[79] J. Modiano,et al. Negative regulators in homeostasis of naïve peripheral T cells , 2008, Immunologic research.
[80] R. Schwartz. T cell anergy. , 1993, Scientific American.
[81] K. Lafferty,et al. A new analysis of allogeneic interactions. , 1975, The Australian journal of experimental biology and medical science.
[82] N. Hay,et al. The two TORCs and Akt. , 2007, Developmental cell.
[83] David K. Finlay,et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking , 2008, Nature Immunology.
[84] C. Janeway,et al. How does the immune system distinguish self from nonself? , 2000, Seminars in immunology.
[85] S. Schreiber,et al. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[86] M. Matsuo,et al. Inhibition of amino acid-mTOR signaling by a leucine derivative induces G1 arrest in Jurkat cells. , 2003, Biochemical and biophysical research communications.
[87] R. D. Hatton,et al. Developmental plasticity of Th17 and Treg cells. , 2009, Current opinion in immunology.
[88] C. Thompson,et al. IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1 , 2001, The Journal of Immunology.
[89] V. Basso,et al. Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin1 , 2006, The Journal of Immunology.
[90] J. Curtsinger,et al. Inflammatory cytokines as a third signal for T cell activation. , 2010, Current opinion in immunology.
[91] J. Powell,et al. Dissecting the mechanism of T-cell anergy with immunophilin ligands. , 2006, Current opinion in investigational drugs.
[92] Daniel R. Beisner,et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor , 2009, Nature Immunology.
[93] Russell G. Jones,et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.
[94] Loise M. Francisco,et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells , 2009, The Journal of experimental medicine.
[95] P. Worley,et al. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals , 1997, Molecular and cellular biology.
[96] R. Negrin,et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. , 2008, Blood.
[97] K. Frauwirth,et al. Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.
[98] C. Barnes,et al. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. , 1994, The Journal of biological chemistry.
[99] C. Proud,et al. Amino acids and mTOR signalling in anabolic function. , 2007, Biochemical Society transactions.
[100] Shailendra Giri,et al. 5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.
[101] T. Weichhart,et al. The multiple facets of mTOR in immunity. , 2009, Trends in immunology.
[102] V. Kuchroo,et al. Th17: the third member of the effector T cell trilogy. , 2007, Current opinion in immunology.
[103] V. Basso,et al. Mammalian Target of Rapamycin through Signaling Mediated by the IL-2-Independent T Cell Clonal Expansion Prolonged TCR / CD 28 Engagement Drives , 2006 .
[104] R. Schwartz,et al. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.
[105] W. Hörl,et al. The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.